Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.

PURPOSE To test the hypothesis-given the increasing emphasis on quantitative computed tomographic (CT) phenotypes of chronic obstructive pulmonary disease (COPD)-that a relationship exists between COPD exacerbation frequency and quantitative CT measures of emphysema and airway disease. MATERIALS AND METHODS This research protocol was approved by the institutional review board of each participating institution, and all participants provided written informed consent. One thousand two subjects who were enrolled in the COPDGene Study and met the GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria for COPD with quantitative CT analysis were included. Total lung emphysema percentage was measured by using the attenuation mask technique with a -950-HU threshold. An automated program measured the mean wall thickness and mean wall area percentage in six segmental bronchi. The frequency of COPD exacerbation in the prior year was determined by using a questionnaire. Statistical analysis was performed to examine the relationship of exacerbation frequency with lung function and quantitative CT measurements. RESULTS In a multivariate analysis adjusted for lung function, bronchial wall thickness and total lung emphysema percentage were associated with COPD exacerbation frequency. Each 1-mm increase in bronchial wall thickness was associated with a 1.84-fold increase in annual exacerbation rate (P = .004). For patients with 35% or greater total emphysema, each 5% increase in emphysema was associated with a 1.18-fold increase in this rate (P = .047). CONCLUSION Greater lung emphysema and airway wall thickness were associated with COPD exacerbations, independent of the severity of airflow obstruction. Quantitative CT can help identify subgroups of patients with COPD who experience exacerbations for targeted research and therapy development for individual phenotypes.

[1]  H. Doll,et al.  Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease , 2012, PharmacoEconomics.

[2]  J. Schmier,et al.  The quality of life impact of acute exacerbations of chronic bronchitis (AECB): A literature review , 2005, Quality of Life Research.

[3]  B. Celli,et al.  Gender and COPD in Patients Attending a Pulmonary Clinic , 2005 .

[4]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[5]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[6]  Susan Murray,et al.  Sex differences in severe pulmonary emphysema. , 2007, American journal of respiratory and critical care medicine.

[7]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[8]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[9]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[10]  Edwin K Silverman,et al.  Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.

[11]  G. Donaldson,et al.  COPD exacerbations · 1: Epidemiology , 2006, Thorax.

[12]  B. Celli,et al.  Gender and COPD in patients attending a pulmonary clinic. , 2006, Chest.

[13]  M. Artés,et al.  Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo. , 1999, Respiratory medicine.

[14]  J. Wedzicha,et al.  COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.

[15]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[16]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[17]  W. MacNee,et al.  Airway dimensions in COPD: relationships with clinical variables. , 2010, Respiratory medicine.

[18]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[19]  Meilan K. Han,et al.  Gender and chronic obstructive pulmonary disease: why it matters. , 2007, American journal of respiratory and critical care medicine.

[20]  B. Celli,et al.  BODE index: a new tool to stage and monitor progression of chronic obstructive pulmonary disease. , 2009, Pneumonologia i alergologia polska.

[21]  Johan H C Reiber,et al.  Progression parameters for emphysema: a clinical investigation. , 2007, Respiratory medicine.

[22]  Eric A. Hoffman,et al.  Automatic lung segmentation for accurate quantitation of volumetric X-ray CT images , 2001, IEEE Transactions on Medical Imaging.

[23]  Milan Sonka,et al.  Segmentation and quantitative analysis of intrathoracic airway trees from computed tomography images. , 2005, Proceedings of the American Thoracic Society.

[24]  J. Curtis,et al.  Clinical Significance of Radiologic Characterizations in COPD , 2009, COPD.

[25]  M. Decramer,et al.  Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. , 2010, Respiratory medicine.

[26]  P. Paré,et al.  Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. , 2000, American journal of respiratory and critical care medicine.